Aventis Pharma S.A.

South Korea Pharmaceuticals and Healthcare Report Q1 2010 - South Korea's Pharmaceutical Market Expected to be Worth US$9.36bn by the End of 2009.
M2 Presswire; 12/9/2009; 1124 words; ...Q1 2010 - South Korea's Pharmaceutical Market...56d353/south_korea_pharma) has announced the addition...Monitor International's South Korea Pharmaceuticals...Pfizer - Sanofi-Aventis - Merck & Co - Novartis...56d353/south_korea_pharma CONTACT: Laura Wood...

Research and Markets Adds: Indonesia Pharmaceuticals and Healthcare Report Q1 2010.
Health & Beauty Close-Up; 12/9/2009; 1300 words; ...Indonesia. The company's operations will be supported by PT Pharma Metric Labs, an Indonesian...Asian assets to Japan's Taisho Pharmaceuticals...Mentioned: - Sanofi-Aventis - Pfizer - Novartis...PT Bio Farma - Kimia Pharma - PT Sido Muncul - Combiphar...

Be Smoke Free & Treatments of Cancer.
M2 Presswire; 12/8/2009; 1180 words; ...antibodies. Two of Micromet's BiTE antibodies and three...clinical trials. Micromet's preclinical product pipeline...platform technology. Micromet's collaboration partners include sanofi-aventis, Bayer Schering Pharma, Nycomed, Merck Serono...

Research and Markets Offers Report: Cancer Drug Discoveries: What the Future Holds: Prostate Cancer Chapter
Wireless News; 12/8/2009; 981 words; ...bicalutamide), Abbott/ Takeda's Lupron/Lupron Depot (leuprolide...intramuscular depot) and sanofi-aventis/Astellas Pharma's Eligard (leuprolide subcutaneous depot). In addition, sanofi-aventis' Taxotere (docetaxel) has become...

Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman.
Cancer Weekly; 12/8/2009; 978 words; ...forward to chairing Ligon's Board, and contributing...found intractable. Ligon's unique and proprietary...Ph.D. is a seasoned pharma and biotech industry leader...management positions at Aventis, Hoechst Marion Roussel...Center. Dr. De Souza's particular focus has been...